DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Grisham RN, Iyer G, Garg K. et al.
BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer.
Cancer 2013;
119: 548-554
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.